Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Immune deficiency of diverse etiology, including human immunodeficiency virus (HIV), antineoplastic agents, immunosuppressive agents used in solid organ recipients, immunomodulatory therapy, and other biologics, all promote invasive fungal infections. Subsequent voluntary or unintended immune recovery may induce an exaggerated inflammatory response defining immune reconstitution inflammatory syndrome (IRIS), which causes significant mortality and morbidity. Fungal-associated IRIS raises several diagnostic and management issues. Mostly studied with Cryptococcus, it has also been described with other major fungi implicated in human invasive fungal infections, such as Pneumocystis, Aspergillus, Candida, and Histoplasma. Furthermore, the understanding of IRIS pathogenesis remains in its infancy. This review summarizes current knowledge regarding the clinical characteristics of IRIS depending on fungal species and existing strategies to predict, prevent, and treat IRIS in this patient population, and tries to propose a common immunological background to fungal IRIS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 2×
“Precursor T helper cells (Th0) differentiate into Th1, Th17, or Th2 cells or Tregs according to cytokines produced in the surrounding milieu through induction of specific transcription factor expression: FOXP3/STAT-5, GATA-3/STAT-6, T-bet/STAT-4, and ROR-γt/STAT-3 for Treg, Th2, Th1, and Th17, respectively [60,61].”
Background(2014) · doi:10.1128/cmr.00126-13 · Cited by 437
Cryptococcal Interactions with the Host Immune System
Voelz, K., & May, R. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00039-10 · Cited by 202 · cited 1×
“Firstly, Cryptococcus itself inhibits the Th1 response while inducing a Th2 response that compromises the host’s resistance in mice [86].”
BackgroundMiceli, M. H., Maertens, J., Buvé, K., Grazziutti, M., Woods, G., Rahman, M., Barlogie, B., & Anaissie, E. J. (2007) · Cancer · doi:10.1002/cncr.22738 · Cited by 163 · cited 5×
“in Table 1, include non-specific worsening, or new onset, of hypoxia, chest pain, cough, dyspnea, and hemoptysis [26].”
BackgroundInfluentialAdjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis
Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P.-S., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/527390 · Cited by 157 · cited 2×
“This granulomatous reaction is described as clusters of epithelioid macrophages, which are sometimes vacuolated and always CD68-positive [57,58].”
BackgroundSelf-citationChoi, E. H., Foster, C. B., Taylor, J. G., Erichsen, H. C., Chen, R. A., Walsh, T. J., Anttila, V., Ruutu, T., Palotie, A., & Chanock, S. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/368345 · Cited by 52
Is there a role for statins in fungal infections?
Bergman, P. W., & Björkhem-Bergman, L. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.856755 · Cited by 12 · cited 1×
“However, a meta-analysis of five retrospective studies showed no positive effects during fungal infections [110].”
Background
Cited by
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50
Gander-Bui, H. T. T., Schläfli, J., Baumgartner, J., Walthert, S., Genitsch, V., van Geest, G., Galván, J. A., Cardozo, C., Graham Martinez, C., Grans, M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.023 · Cited by 47
Tocilizumab Induces IL-10-Mediated Immune Tolerance in Invasive Candidiasis
Tan, Z., Mok, M. M. H., Mar Soe, W., Thamboo, T. P., Goh, J. G., Sam, Q. H., Osato, M., Ravikumar, S., & Chai, L. Y. A. (2021) · Journal of Fungi · doi:10.3390/jof7080656 · Cited by 6
“A state of immune reconstitution inflammatory syndrome existent in fungal infections is progressively being recognized [6,7] as a rationale to explain the unanticipated clinical deterioration at times after the initiation of anti-fungal treatment.”
Background
Metadata
- Authors
- Dellière, S., Guery, R., Candon, S., Rammaert, B., Aguilar, C., Lanternier, F., Chatenoud, L., & Lortholary, O.
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2018-12-17
- Volume
- 4
- Issue
- 4
- Pages
- 139
- ISSN
- 2309-608X (ISSN-L)
- OpenAlex
- W2904471753
- Cited by
- 60
- References
- 9
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections. https://app.cochat.ai/papers/10.3390/jof4040139
- The paper
- Dellière, S., Guery, R., Candon, S., Rammaert, B., Aguilar, C., Lanternier, F., Chatenoud, L., & Lortholary, O. (2018). Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections. Journal of Fungi. https://doi.org/10.3390/jof4040139
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.